Filtros de búsqueda

Lista de obras de David J Moliterno

2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Hear

artículo científico

A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes

artículo científico publicado en 2006

A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study

artículo científico publicado en 2003

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abcixi

artículo científico publicado el 11 de enero de 2011

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

artículo científico publicado en 2008

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

artículo científico publicado en 2008

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

artículo científico publicado en 2009

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, Am

artículo científico publicado en 2011

Advances in antiplatelet therapy for ACS and PCI.

artículo científico publicado en 2008

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

artículo científico publicado en 2016

American College of Cardiology Annual Scientific Session 2010: update in interventional cardiology

artículo científico publicado en 2010

An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.

artículo científico publicado en 2002

Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial

artículo científico publicado en 2003

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update

artículo científico publicado en 2016

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary

artículo científico publicado en 2011

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

artículo científico publicado en 2015

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

artículo científico publicado en 2003

Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries.

artículo científico publicado en 2002

Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes

artículo científico publicado en 2003

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

artículo científico publicado en 2013

Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes

artículo científico publicado en 2004

Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy

artículo científico publicado en 2005

Association of race with complications and prognosis following acute coronary syndromes

artículo científico publicado en 2004

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

artículo científico publicado en 2012

Being a Great Reviewer: Remembering the "Why"

artículo científico publicado en 2018

Beyond Aspirin and Clopidogrel: Is There a Need for Additional Antiplatelet Therapy in ACS? ⬇️

artículo científico publicado el 1 de agosto de 2011

Bifurcation stenting techniques and outcomes in patients with stable coronary artery disease: more evidence suggesting simpler is safer

artículo científico publicado en 2015

Brachytherapy for in-stent restenosis: a distant second choice to drug-eluting stent placement

artículo científico publicado en 2006

CT Angiography for Emergency Decision Making in Acute Coronary Syndromes: Applying Future Vision Now ⬇️

artículo científico publicado el 1 de octubre de 2012

CTO-Chronic Total Occlusions and Continuous Training Opportunity

artículo científico publicado en 2017

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

artículo científico publicado en 2013

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2017

Clopidogrel for percutaneous coronary revascularization: time for more pretreatment, retreatment, or both?

artículo científico publicado en 2005

Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention

artículo científico publicado en 2006

Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel

artículo científico publicado en 2005

Combining antiplatelet and anticoagulant therapies

artículo científico publicado en 2009

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

artículo científico publicado en 2004

Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective

artículo científico publicado en 2011

Contemporary use of antiplatelet therapies in percutaneous coronary interventions

artículo científico publicado en 2003

Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin

artículo científico publicado en 2009

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

artículo científico publicado en 2016

Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations ⬇️

artículo científico publicado el 1 de mayo de 2003

Drug–Drug Interactions in Cardiovascular Catheterizations and Interventions ⬇️

artículo científico publicado el 1 de diciembre de 2012

Early statin initiation and outcomes in patients with acute coronary syndromes

artículo científico publicado en 2002

Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trial

artículo científico publicado en 2003

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2016

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

artículo científico publicado en 2004

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

artículo científico publicado en 2013

Effectiveness of drug-eluting stents in real-world patients

artículo científico publicado en 2008

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

artículo científico publicado en 2006

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

artículo científico publicado en 2015

Enoxaparin in clinical practice and clinical trials of non-ST-elevation Acute Coronary Syndrome (NSTE-ACS).

artículo científico publicado en 2005

Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry

artículo científico publicado en 2009

Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels

artículo científico publicado en 2003

Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients

artículo científico publicado en 2003

Fractionating heparins and their clinical trial data--something for everyone

artículo científico publicado en 2004

Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

artículo científico publicado en 2003

G-protein-coupled receptors as signaling targets for antiplatelet therapy

artículo científico publicado en 2008

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

artículo científico publicado en 2015

Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction

artículo científico publicado en 2002

Glycoprotein IIb/IIIa combination therapy in acute myocardial infarction: tailoring therapies to optimize outcome

artículo científico publicado en 2002

Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET.

artículo científico publicado en 2003

Healing Achilles--sirolimus versus paclitaxel

artículo científico publicado en 2005

Heparin-induced thrombocytopenia and cardiovascular diseases

artículo científico publicado en 2006

Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial

artículo científico publicado en 2010

Hybrid coronary revascularization: Time for a new comparator?

artículo científico publicado en 2018

Imminent extinction of brachy(saurus)therapy for the treatment of in-stent restenosis

artículo científico publicado en 2006

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

artículo científico publicado en 2002

Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up

artículo científico publicado en 2002

Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization

artículo científico publicado en 2006

In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?

artículo científico publicado en 2007

In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

artículo científico publicado en 2009

Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy

artículo científico publicado en 2008

Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry

artículo científico publicado en 2017

International variation in invasive care of the elderly with acute coronary syndromes

artículo científico publicado en 2006

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy

artículo científico

Late drug-eluting stent thrombosis in unprotected left main coronary artery lesions--sometimes possible, but rarely definite or probable

artículo científico publicado en 2008

Late percutaneous recanalization of totally occluded infarct-related arteries--more than about time

artículo científico publicado en 2008

Late target lesion revascularization following drug-eluting stents - looking back and forward to success

artículo científico publicado en 2008

Left main dissection and thrombosis in a young athlete

artículo científico publicado en 2005

Little Kids, Little Problems-Big Kids, Big Problems

artículo científico publicado en 2017

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus

artículo científico publicado en 2002

Managing unstable angina in high-risk patients.

artículo científico publicado en 2002

Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites

artículo científico publicado en 2007

Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction

artículo científico

More Time to SORT OUT Clinical Outcomes After First-Generation Drug-Eluting Stents: Related Versus Unrelated Events

artículo científico publicado en 2017

Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up

artículo científico publicado en 2005

New Anticoagulants in Ischemic Heart Disease ⬇️

artículo científico publicado el 1 de agosto de 2012

Non-invasive assessment of plaque morphology and remodeling in mildly stenotic coronary segments: comparison of 16-slice computed tomography and intravascular ultrasound

artículo científico publicado en 2003

Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites

artículo científico publicado en 2017

One Man's Vacation, Another Man's Stress Test

artículo científico publicado en 2017

Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) study

artículo científico publicado en 2007

Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era.

artículo científico publicado en 2006

Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study

artículo científico publicado en 2002

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials

artículo científico publicado en 2004

Patient, Heal Thyself: The Ongoing Evolution of Patient Self-directed Care and Hand-Held Technology ⬇️

artículo científico publicado el 5 de abril de 2011

Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization

artículo científico publicado en 2003

Platelet protease-activated receptor antagonism in cardiovascular medicine ⬇️

artículo científico publicado el 1 de septiembre de 2012

Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration

artículo científico publicado en 2004

Potential hazards of adding nonsteroidal anti-inflammatory drugs to antithrombotic therapy after myocardial infarction: time for more than a gut check

artículo científico publicado en 2015

Prasugrel versus clopidogrel in primary PCI: considerations of the TRITON-TIMI 38 substudy

artículo científico publicado en 2009

Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis

artículo científico publicado en 2004

Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction

artículo científico publicado en 2002

President's page: drug-eluting stents in contemporary practice--a call for a real-world, open-entry, device-tracking registry

artículo científico publicado en 2007

Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and [...]

artículo científico publicado en 2007

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

artículo científico publicado en 2018

Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification

artículo científico publicado en 2003

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy

artículo científico publicado en 2013

Prognostic significance of elevated troponin I after percutaneous coronary intervention

artículo científico publicado en 2002

Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).

artículo científico publicado en 2002

QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study

artículo científico publicado en 2013

Racial differences in outcome following percutaneous coronary intervention

artículo científico publicado en 2008

Randomized trial versus registry data--comparing apples and ORCHIDs

artículo científico publicado en 2006

Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization

artículo científico publicado en 2004

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.

artículo científico publicado en 2014

Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention

artículo científico publicado en 2004

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes

artículo científico publicado en 2004

Remote ischemic preconditioning in elective percutaneous coronary intervention does not protect myocardium nor mobilize endothelial progenitor cells

artículo científico publicado en 2013

Renal function, concomitant medication use and outcomes following acute coronary syndromes

artículo científico publicado en 2005

Research Correspondence: One Good Point, One Great Figure (or Table).

artículo científico publicado en 2017

Resistance to antiplatelet resistance is it justified?

artículo científico publicado en 2005

Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents

artículo científico publicado en 2007

Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation

artículo científico publicado en 2003

Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old.

artículo científico publicado en 2003

Role of cardiac computed tomography and magnetic resonance imaging in the evaluation of acute chest pain in the emergency department

artículo científico publicado en 2007

Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition

artículo científico publicado en 2003

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

artículo científico publicado en 2009

Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials

artículo científico publicado en 2015

Second-generation drug-eluting stents and the continuous need for rapidly available real-world data

artículo científico publicado en 2009

Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents

artículo científico publicado en 2016

Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years

artículo científico publicado en 2015

Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).

artículo científico publicado en 2009

Stent thrombosis

artículo científico publicado en 2010

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes

artículo científico publicado en 2002

The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)

artículo científico publicado en 2005

The Top Papers of 2017: By Subsequent Citations and Online Views and Downloads

artículo científico publicado en 2018

The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy

artículo científico publicado en 2002

The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.

artículo científico publicado en 2004

The evolution of a Department of Internal Medicine under an integrated clinical enterprise model: the University of Kentucky experience

artículo científico publicado en 2010

The evolving role of cardiac troponin in the evaluation of cardiac disorders

artículo científico publicado en 2013

The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial

artículo científico publicado en 2005

The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice

artículo científico publicado en 2006

The role of the platelet in the pathogenesis of atherothrombosis

artículo científico publicado en 2005

The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide

artículo científico publicado en 2008

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

artículo científico publicado en 2011

Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting

artículo científico publicado en 2004

Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry

artículo científico publicado en 2016

Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials

artículo científico publicado en 2009

Tissue necrosis factor α and targeting its receptor in ischaemic heart disease

artículo científico publicado en 2013

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

artículo científico publicado en 2017

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years

artículo científico publicado en 2012

Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices

artículo científico publicado en 2004

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)

artículo científico publicado en 2003

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

article by Albert W Chan et al published October 2003 in Journal of the American College of Cardiology

Unfortunate impact of age on the management and outcomes of unstable angina and non-ST elevation myocardial infarction (The GUARANTEE Registry).

artículo científico publicado en 2005

Unraveling questions surrounding clopidogrel resistance and stent thrombosis: one less snag

artículo científico publicado en 2007

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials

artículo científico publicado en 2011

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

artículo científico publicado en 2016

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

artículo científico publicado en 2014

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

artículo científico publicado en 2016

Value of high-sensitivity troponin in assessing the extent of benefit provided by ticagrelor versus clopidogrel in non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2013

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

artículo científico publicado en 2013

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).

artículo científico publicado en 2014

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

artículo científico publicado en 2014

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

artículo científico publicado en 2014

White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).

artículo científico publicado en 2017

unfractionated versus low‐molecular‐weight heparin for primary angioplasty—More data suggesting to go low ⬇️

artículo científico publicado el 1 de febrero de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda